CTOs on the Move

Advanced Cardiac Therapeutics Inc

www.actmed.net

 
Advanced Cardiac Therapeutics, Inc. is a pre-commercial, medical device company that designs and manufactures a catheter-based system for the treatment of patients with AFIB. AFIB is characterized by an irregular, often rapid heart rate that commonly causes poor systemic blood flow. The Company`s mission is to dramatically improve the treatment of AFIB through the introduction of products based on its proprietary catheter and generator system. ACT`s technology is the only system in the world to leverage feedback from four unique capabilities: temperature sensing, low irrigation flow rates, high resolution EGM attenuation and contact sensing. The ACT ...
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million
  • www.actmed.net
  • 1278 Glenneyre Suite 139
    Laguna Beach, CA USA 92651
  • Phone: 949.500.0192

Executives

Name Title Contact Details

Funding

Advanced Cardiac Therapeutics Inc raised $45M on 05/02/2017

Similar Companies

Vestergaard Frandsen

Vestergaard Frandsen is a Arlington, VA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Osceola Supply Inc

Osceola Supply Inc is a Tallahassee, FL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Advanced Brain Monitoring

Advanced Brain Monitoring is a Carlsbad, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Healthline Med

Healthline Med is a Baldwin Park, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

C. R. Bard

C. R. Bard is a leading multinational developer, manufacturer, and marketer of innovative, life-enhancing medical technologies in the fields of Vascular, Urology, Oncology, and Surgical Specialties. Bard markets its products and services worldwide to hospitals, individual health care professionals, extended care facilities, and alternate site facilities. Bard pioneered the development of single-patient-use medical products for hospital procedures; today Bard is dedicated to pursuing technological innovations that offer superior clinical benefits while helping to reduce overall health care costs.